Rakuten Medical, Inc.
The Associate Director/Director, Global Safety Operations leads pharmacovigilance and safety operations for pre-approval clinical development programs and post-marketing products at Rakuten Medical. This role ensures compliance with global and local regulatory requirements while overseeing safety information management, reporting, and vendor management. The position involves driving the development and standardization of global safety processes and collaborating with cross-functional teams to support the entire product lifecycle.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2010
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell‑targeting investigational therapies to treat cancer. Its Alluminox™ technology platform employs targeted agents that, when activated, have been shown in preclinical studies to induce rapid and selective cell killing and tumor necrosis. Rakuten Medical is committed to its mission to conquer cancer and to advancing therapies that help patients lead fulfilling lives.
Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval
Jan 7, 2026
Rakuten Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15th, 2026
Dec 18, 2025
Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rakuten Medical, Inc..
62% below the average for this role
Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
Jan 13, 2026
Senior Director, Global Patient Safety - Rare Disease
Regeneron Pharmaceuticals
Director, Global Safety Lead
Servier
Director, Global Patient Safety Sciences - Oncology
Regeneron Pharmaceuticals
Director, Global Drug Safety & Pharmacovigilance Operations
Asahi Kasei Therapeutics
Senior Medical Director, Neuroscience, Global Patient Safety
AbbVie
Medical Director, Neuroimmunology, Global Patient Safety
AbbVie